Hanmi’s Hyaluma inj. wins SCG certification

Published: 2012-04-04 06:57:00

Updated: 2012-04-04 06:57:00

Hanmi Pharmaceutical said Monday that it has acquired the British SGS (Society of General Surveillance) certification for Hyaluma injection (sodium hyaluronate as a medical device.

Sodium hyaluronate is used as a viscosupplement, administered through a series of injections into the knee, incre...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK